Related Experiment Videos
Evaluation of progression and spread of atherothrombosis
Dirk W Droste1, E Bernd Ringelstein
1Department of Neurology, University of Münster, Germany. droste2@uni-muenster.de
Insights
Atherothrombosis often affects multiple vascular beds, increasing ischemic event risk. Early detection using ankle-brachial index (ABI) guides aggressive antiplatelet therapy for better cardiovascular risk management.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Clinical Diagnostics
Background:
- Symptomatic atherothrombosis in one vascular area frequently indicates widespread disease, posing a significant risk for ischemic events.
- Understanding the generalized nature of atherothrombosis is crucial for effective patient management and prevention strategies.
- Specific risk factors like smoking and hypertension show domain affinities, influencing atherosclerosis patterns.
Observation:
- Atherosclerosis progression and extent can be evaluated using diverse non-invasive and invasive techniques.
- Key indicators of atherothrombotic risk include elevated carotid artery intima-media thickness, microembolic signals, and a low ankle-brachial index (ABI).
- The ankle-brachial index (ABI) is a valuable tool for assessing cardiovascular risk in patients with known risk factors.
Findings:
- A low ABI is a strong indicator of generalized atherothrombosis and heightened ischemic event risk.
- Routine ABI measurement is recommended for cardiovascular risk assessment in at-risk individuals.
- Identifying a low ABI should prompt aggressive antiplatelet therapy.
Implications:
- Integrating ABI measurement into routine examinations can significantly improve cardiovascular risk stratification.
- Early detection of disseminated atherothrombosis via ABI enables timely and aggressive therapeutic interventions.
- This approach highlights the importance of a holistic view of atherothrombosis for preventing future ischemic events.
Abstract:
Symptomatic atherothrombosis in one vascular bed is usually indicative of disseminated disease. Indeed, involvement of multiple beds is common in everyday clinical practice, and these patients are at much higher risk of ischaemic events. The prevention of manifestations following atherothrombosis is therefore an important therapeutic goal in these patients. Some causative risk factors demonstrate affinities to particular arterial domains. Cigarette smoking, for example, is particularly associated with atherothrombotic involvement of the pelvic and lower limb arteries, whereas arterial hypertension is associated with the intracranial cerebral arteries. The degree, spread and progression of atherosclerosis can be assessed using various non-invasive and invasive modalities: high-resolution Doppler ultrasound, ankle-brachial index (ABI) measurement, magnetic resonance (MR), computed tomography (CT) and intra-arterial angiography. Indicators of atherothrombotic risk include increased carotid artery intima-media thickness, microembolic signals on transcranial Doppler ultrasonography and low ABI. There is a strong rationale for the inclusion of the ABI measurement as part of the routine clinical examination to assess the cardiovascular risk in patients with identified risk factors. Furthermore, detection of a low ABI should serve as a trigger for patient management with aggressive antiplatelet therapy. The generalized nature of atherothrombosis and the methods for evaluating the spread of disease are illustrated through the case history of a patient with disseminated atherothrombotic disease.